Apyx Medical (APYX) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Apyx Medical (APYX) over the last 14 years, with Q3 2025 value amounting to -$2.0 million.
- Apyx Medical's Income towards Parent Company rose 5861.56% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.5 million, marking a year-over-year increase of 4908.15%. This contributed to the annual value of -$23.6 million for FY2024, which is 2498.14% down from last year.
- According to the latest figures from Q3 2025, Apyx Medical's Income towards Parent Company is -$2.0 million, which was up 5861.56% from -$3.7 million recorded in Q2 2025.
- Apyx Medical's Income towards Parent Company's 5-year high stood at -$1.0 million during Q2 2023, with a 5-year trough of -$9.6 million in Q4 2023.
- For the 5-year period, Apyx Medical's Income towards Parent Company averaged around -$4.8 million, with its median value being -$4.7 million (2023).
- Its Income towards Parent Company has fluctuated over the past 5 years, first skyrocketed by 8130.28% in 2023, then crashed by 54631.99% in 2024.
- Apyx Medical's Income towards Parent Company (Quarter) stood at -$2.0 million in 2021, then tumbled by 201.74% to -$6.1 million in 2022, then plummeted by 58.68% to -$9.6 million in 2023, then surged by 51.59% to -$4.7 million in 2024, then soared by 58.04% to -$2.0 million in 2025.
- Its last three reported values are -$2.0 million in Q3 2025, -$3.7 million for Q2 2025, and -$4.2 million during Q1 2025.